CELSR2 and glioma: To further confirm whether CELSR2 is involved in the regulation of Wnt/β-catenin signaling pathway to influence proliferation and cell cycle of glioma cells, we used the GSK-3β inhibitor TWS119 to activate Wnt/β-catenin.